Adverse clinical outcomes in adult cases of encephalitis

December 03, 2019

Share article

Despite encephalitis being associated with significant morbidity and mortality, the aetiology is unknown in the majority of patients. The authors describe a retrospective cohort of encephalitis cases in 19 hospitals from New Orleans, Louisiana and Houston, Texas between 2000–2017. 340 adults (aged ≥17 years) with confirmed encephalitis were enrolled, 57% of whom had unknown aetiologies. PCR of the CSF for herpes simplex virus (HSV) and varicella zoster virus was performed in 69% and in 24% of patients, respectively. In addition, arboviral serology was performed on 49% of patients and anti-N-methyl-D-aspartate receptor antibody levels measured in 14%. 53% of the patients experienced adverse clinical outcomes (ACO) upon discharge. Older patients (>65 years of age) had a lower prevalence of HIV, higher number of comorbidities, were less likely to receive adjuvant steroids, and were more likely to have a positive arbovirus serology, a positive HSV PCR, abnormal CT findings and to have ACO. Prognostic factors that were independently associated with an ACO were age ≥65 years, fever, Glasgow coma scale (GCS) <13 and seizures. Therefore encephalitis leads to adverse clinical outcomes and has an unknown aetiology in the majority of patients, despite molecular diagnostics.

Read more here

Hansen MA, Samannodi MS, Castelblanco RL & Hasbun R ISSN: Clin Infect Dis; pii: ciz635


Added: December 03, 2019